Tommy Kenny
Algemeen Adviseur bij INTELGENX TECHNOLOGIES CORP.
Vermogen: 27 931 $ op 30-04-2024
Profiel
Tommy Kenny has held multiple positions in the legal field.
He is currently the Vice President-Legal Affairs & General Counsel at Intelgenx Corp.
and has been in this role since 2021.
Prior to this, he served as the Senior Vice President & General Counsel at IntelGenx Technologies Corp.
starting in 2016.
Additionally, Mr. Kenny currently works as an Associate at Brouillette & Partners.
In terms of education, Mr. Kenny holds a graduate degree from the University of Sherbrooke and a undergraduate degree from Bishop's University.
He also obtained a graduate degree from the University of Montreal Law School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 29-01-2024 | 167 250 ( 0.10% ) | 27 931 $ | 30-04-2024 |
Actieve functies van Tommy Kenny
| Bedrijven | Functie | Begin |
|---|---|---|
| INTELGENX TECHNOLOGIES CORP. | Algemeen Adviseur | 01-01-2016 |
Intelgenx Corp.
 Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Algemeen Adviseur | 01-01-2021 |
| Brouillette & Partners | Corporate Officer/Principal | - |
Opleiding van Tommy Kenny
| University of Montreal Law School | Graduate Degree |
| University of Sherbrooke | Graduate Degree |
| Bishop's University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INTELGENX TECHNOLOGIES CORP. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Health Technology |
| Brouillette & Partners |
